You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSRV-Envelope protein

Showing 1 - 25 of 9,311
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial (763SIP8/MPLA-5 vaccine)

Not yet recruiting
  • Healthy
  • 763SIP8/MPLA-5 vaccine
  • (no location specified)
Mar 15, 2023

HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam University Medical Centers, location AMC
Jan 31, 2023

HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,

Recruiting
  • HIV Infection
  • ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
  • Normal saline solution
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Jul 11, 2022

HIV Trial in Boston, Seattle, Nairobi (BG505 SOSIP.664 gp140, adjuvanted, Placebo)

Active, not recruiting
  • HIV Infections
  • BG505 SOSIP.664 gp140, adjuvanted
  • Placebo
  • Boston, Massachusetts
  • +2 more
May 6, 2022

HIV Trial in Saint Louis (gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • gp160 Vaccine (MicroGeneSys)
  • Saint Louis, Missouri
    St. Louis Univ. School of Medicine AVEG
Oct 27, 2021

HIV Trial in United States (MF59, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • MF59
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

HIV Trial in Saint Louis, Pittsburgh (gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • gp160 Vaccine (MicroGeneSys)
  • Saint Louis, Missouri
  • +1 more
Oct 27, 2021

HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +7 more
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

HIV Trial in Pittsburgh, Nashville (Hepatitis B Vaccine (Recombinant), gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • Hepatitis B Vaccine (Recombinant)
  • gp160 Vaccine (MicroGeneSys)
  • Pittsburgh, Pennsylvania
  • +1 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 28, 2021

HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 27, 2021

HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

Recruiting
  • HIV Infections
  • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
  • +3 more
  • Columbus, Ohio
  • +1 more
Apr 10, 2022

Healthy Volunteers Trial in Berlin (GNbAC1)

Completed
  • Healthy Volunteers
  • Berlin, Germany
    PAREXEL Early Phase Clinical Unit
Oct 19, 2020

HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • +4 more
  • Rochester, New York
  • +1 more
Oct 28, 2021

HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP
  • +4 more
  • London, United Kingdom
    NIHR Imperial Clinical Resarch Facility
Jul 25, 2022

HIV Trial in Puerto Rico, United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • +2 more
  • Long Beach, California
  • +33 more
Oct 27, 2021

MSRV-Env Burden in Normal Population

Completed
  • Multiple Sclerosis
  • No study treatments administered
  • Annemasse, France
    Etablissement Français du Sang Rhône Alpes - 1 route de Taninges
Oct 19, 2020

MSRV-Env Burden in Patients With Multiple Sclerosis Disease

Completed
  • Multiple Sclerosis (MS)
  • +4 more
  • No study treatments administered - blood draws only
  • Bron cedex, France
  • +3 more
Oct 19, 2020

HIV Trial in Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Seattle, Washington
    Children's Hospital & Medical Center / Seattle ACTU
Oct 26, 2021

HIV Trial in United States (TBC-3B Vaccine, Smallpox Vaccine)

Completed
  • HIV Infections
  • TBC-3B Vaccine
  • Smallpox Vaccine
  • Saint Louis, Missouri
  • +4 more
Oct 27, 2021

HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

Recruiting
  • HIV-1-infection
  • INO-6160, 2 mg
  • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
  • New York, New York
  • +2 more
Apr 13, 2023

HIV Trial in Boston, Johannesburg, Cape Town (Sub C gp140 Vaccine, MF59C.1 Adjuvant, Sodium chloride)

Completed
  • HIV Infections
  • Sub C gp140 Vaccine
  • +2 more
  • Boston, Massachusetts
  • +3 more
Oct 13, 2021

Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,

Recruiting
  • Chronic HBV Infection
  • Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
  • +2 more
  • Beijing, Beijing, China
  • +7 more
Feb 23, 2023

Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

Active, not recruiting
  • Chronic Hepatitis B and Hepatitis D Co-infection
  • HH-003 20mg/kg
  • HH-003 3mg/kg
  • Changchun, Jilin, China
    First Hospital of Jilin University
Dec 30, 2022

Virus Diseases Trial in London (ConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug)

Active, not recruiting
  • Virus Diseases
  • ConM SOSIP 50 ug and ConS UFO 50 ug
  • +4 more
  • London, Please Select..., United Kingdom
    NIHR Imperial Clinical Research Facility
Jul 25, 2022